Halma grows healthcare sector with acquisition for €50 million
18 November 2024
Halma, the global group of life-saving technology companies, today announces that it has acquired Lamidey Noury Medical, a leading manufacturer of high-quality medical devices to assist surgeons operate more safely and efficiently.
Lamidey Noury, headquartered in Paris, France, is renowned for its excellence in designing and producing electrosurgical instruments. These instruments, widely adopted by healthcare professionals worldwide, are used for cutting tissue and controlling bleeding during operations, thereby improving patient outcomes and operational efficiencies.
The ageing population and rising incidence of urological and gynaecological diseases in younger patients are driving the demand for specialised medical care. Additionally, global healthcare spending is increasing, reflecting a prioritisation of health and well-being. The adoption of minimally invasive procedures, which offer shorter recovery times and lower risks, is also on the rise, making electrosurgical instruments essential for precise and controlled surgical interventions.
Electrosurgical instruments are part of a broader category of devices that enhance the efficiency and safety of procedures. They are essential in minimally invasive procedures because they allow for more precise and controlled interventions, reducing the risk of complications and improving patient outcomes.
Guillaume Noury, President of Lamidey Noury, said: "Joining Halma is an exciting opportunity for us. Leveraging Halma's expertise, resources, and global reach will accelerate our growth and innovation. We are confident in our ability to continue delivering high-quality surgical tools to our customers worldwide, while providing new opportunities for our employees and stakeholders. Together, we will continue improving patient outcomes and driving excellence in healthcare.”
Marc Ronchetti, Group Chief Executive of Halma, said: “I am excited to welcome Lamidey Noury to Halma. This acquisition aligns perfectly with our mission of improving patient outcomes. Lamidey Noury's innovative solutions will enhance our portfolio of minimally invasive surgical product capabilities. With Halma's global reach and resources, we look forward to supporting its development as it continues to scale its business globally.”
Lamidey Noury will be a standalone company within Halma's Healthcare sector, led by its current management team. This acquisition underscores Halma's commitment to advancing healthcare through innovative solutions and strategic growth.
For further information, please contact:
Halma plc
Marc Ronchetti, Group Chief Executive
Charles King, Head of Investor Relations +44 (0) 7776 685948
Clayton Hirst, Director of Corporate Affairs +44 (0) 7384 796 013
MHP Communications
Oliver Hughes / Rachel Farrington / Ollie Hoare +44 (0)7817 458 804
A copy of this announcement, together with other information about Halma, is available at www.halma.com.
About Halma
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day.
Its purpose defines the three broad market areas where it operates:- Healthcare: meeting rising healthcare demand as growing populations age and lifestyles change.
- Safety: Protecting the safety of people and assets as populations grow and the demand on infrastructure increases.
- Environment: improving food and water quality, and monitoring air pollution.
It employs over 8,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.
For the past six years Halma has been named as one of Britain's Most Admired Companies.
For more information see www.halma.com
Further information on Lamidey Noury
With seven decades of experience in the field of electrosurgery, Lamidey Noury has established itself as a leading provider of innovative and high-quality electrosurgical solutions. Guided by our core values of innovation, excellence, and distinction, we are committed to delivering exceptional products and services to our customers worldwide. With a presence in over 60 markets, we strive to establish solid long-term partnerships with our end-users through our extensive distribution network.
For more information see www.lamidey-noury.com
ENDS.
